SOHOB Q2 2025 Earnings Preferred Stock Reports EPS of 021 Amid Flat Trading STSS Q3 2025 Earnings Losses Widen Sharply as Revenue Remains Absent ASNS Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue Disclosure TAYD Q1 2026 Earnings Modest EPS Beat Drives Positive Stock Reaction Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges OXM Q1 2026 Earnings Major EPS Miss but Stock Surges 8